The report on Drug Discovery Technologies Market by technology type (biochips, high throughput screening,
pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology), end users
(biopharmaceutical, pharmaceutical, research institutes and biotech companies) trends analysis and forecasts
up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North
America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Drug Discovery
Technologies Market is projected to grow at a CAGR of 18.4% in terms of value over the period of 2018-2024.
The growth in the world market is primarily driven by significant contribution by North America (Leading
region) region to this market.
Market Insight:
The growing incidences of diseases, pathogen resistance to old drugs, patent expiries, and competition among
drug manufacturers are the key factors that drive the growth of this market. Moreover, increasing investment
in the field of nanotechnology, biotechnology, genomics, and, molecular biology are some other factor that
has driven this market. Furthermore, long duration of drug discovery process, high initial setup cost and
presence of strict regulatory surroundings.
Segments Covered
The report on global drug discovery technologies market covers segments such as technology type, and end
users. The technology type segments include biochips, high throughput screening, pharmacogenomics,
genomics, bioanalytical instruments, bioinformatics, nanotechnology and others (RNAI, combinatorial
chemistry). On the basis of end users the global drug discovery technologies market is categorized into
biopharmaceutical companies, pharmaceutical companies, research institutes and biotech companies.
Infinium Global Research